Related News
Survival rate of patients with most common type of lung cancer has doubled in 10 years
Online Edition
The survival rate of patients with the most common type of lung cancer more than doubled in the past 10 years, when targeted medicine became available on the Chinese market, experts said a medical forum today.
Non-small-cell lung cancer accounts for 80 percent of all lung cancer cases and 75 percent of patients with such cancer are diagnosed at the terminal stage.
Targeted medicine attacks cancerous tissue with little damage to healthy cells, thus greatly reducing side effects.
The average length of survival has been prolonged from 14.1 months to 33.5 months and the five-year survival rate, which considered as recovery clinically, has increased from 8 percent to 18 percent.
Lung cancer is the most common cancer in China and the country’s biggest cancer killer.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
